Board of Directors
Meet the Board
board-of-directors
Board of Directors
Sabrina Martucci Johnson
Chair; President and CEO
Daré Biosciences
Matthew Bresnahan, J.D.
Vice Chair; Partner
Wilson Sonsini
Susan Krumplitsch
Secretary; Partner
Womble Bond Dickinson US LLP
Kelly Hayes
Treasurer; Assurance Partner
Ernst & Young
Nancy Whiting, Pharm.D.
Chair-Elect; President and CEO
Recludix Pharma
Aliza Apple, Ph.D.
Vice President, Catalyze360 AI/ML
Eli Lilly
Ranjeet Banerjee
CEO
Cold Chain Technologies
Dan Burgess
Chairman
Nabriva Therapeutics, PLC
Aaron K. Cohen
Vice President, Government Affairs and Public Policy, Neurocrine Biosciences
Jennifer Giottonini Cayer
Chief Business Officer
Pulmocide
Thierry Diagana, Ph.D.
Head of Global Health & California Sites Head
Novartis Biomedical Research
Joydeep Ganguly
SVP, Global Operations, Chief Operations and Quality Officer
Agilent
Stephen Hatke
Vice President of Operations & Thousand Oaks Site Head
Takeda
Jeffrey Hessekiel
Executive Vice President, Chief Legal and Administrative Officer
Cytokinetics
Paul Mola
CEO
Armida Labs
Carolyn Ng, Ph.D.
Business Unit Partner
TPG Life Sciences Innovations
Bernard Parker
Managing Director
Caligen Bio
Ken Rollins
Partner
Cooley
Christophe Schilling, Ph.D.
Co-Founder
Geno
Tim Scott
President & CEO
Biocom
John Sos
SVP & Group President Life Sciences Solutions Group
Thermo Fisher Scientific
Nick Tait
Principal,
Marsh & McLennan Agency